Prenetics Global Ltd SEC filings PRE
Prenetics Global Ltd has 271 filings in SEC EDGAR's recent list, going back to Sep 16, 2021. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 4, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 24, 2026 |
| 3 | Initial insider ownership | Aug 26, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 3 | Initial insider ownership | Aug 12, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 4, 2026 |
| 3 | Initial insider ownership | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 4, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 3 | Initial insider ownership | Jun 15, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 3/A | Form 3/a | May 28, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 22, 2026 | — |
| 3 | Initial insider ownership | Mar 30, 2026 | Mar 26, 2026 |
| 3 | Initial insider ownership | Mar 30, 2026 | Mar 26, 2026 |
| 3 | Initial insider ownership | Mar 24, 2026 | Mar 24, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 5, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 27, 2023 | — |
| SC 13D | Ownership over 5% (active) | Aug 7, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 25, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 27, 2023 | — |
| SC 13D | Ownership over 5% (active) | Mar 27, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 25, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Aug 17, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Jun 29, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Jun 8, 2022 | — |
| SC 13G | Ownership over 5% (passive) | May 31, 2022 | — |
| SC 13D | Ownership over 5% (active) | May 31, 2022 | — |
| SC 13G | Ownership over 5% (passive) | May 31, 2022 | — |
| SC 13G | Ownership over 5% (passive) | May 27, 2022 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRE (Nasdaq), PRENW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Quarry Bay, Hong Kong
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1876431
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.